Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06349850

Predictive Value of Serum Uric Acid to HDL Cholesterol Ratio for Diabetic Kidney Injury in Type 2 Diabetes

Predictive Value of Serum Uric Acid to High Density Lipoprotein Cholesterol Ratio for Diabetic Kidney Injury in Type 2 Diabetes

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

An prospective observetional study to asses the predictive value of serum uric acid to high density lipoprotein cholesterol ratio for diabetic kidney injury in type 2 diabetes

Detailed description

Diabetic Kidney Injury (DKI) is a serious microvascular complication of diabetes mellitus occuring in about 20 % to 50% of diabetic patients and is the single commonest cause of ESRD.DKI is asociated with arterial HTN and increased cardiovascular morbidity and mortality. outcomes for both type 1 DM and type 2 DM who develop DKI are significantly worse than who do not .Serum uric acid was reported to be asociated with inflamatory and metabolic diseases such as metabolic syndrome , type 2 DM,thyroiditis and NAFLD while HDL-cholesterol decreased the odds of developing DKI by 20%.It is generally accepted that hyperuricemia and low HDL-c were considered to be a risk factor of other indicators for development of DKI.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTserum uric acid level to plasma HDL-c level ratio (UHR)high UHR is considered to be a risk factor for development of DKI in type 2 DM

Timeline

Start date
2024-06-01
Primary completion
2024-09-01
Completion
2024-09-01
First posted
2024-04-05
Last updated
2024-05-16

Source: ClinicalTrials.gov record NCT06349850. Inclusion in this directory is not an endorsement.